Drugs News and Research

RSS

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.

6 Jun 2013

State highlights: Conn. bill would maintain coverage for low-income parents; Wis. may pay hospitals for uninsured care; Is hospital data sale a risk to patient privacy?

The House of Representatives adopted an omnibus bill Tuesday to implement numerous social service policy changes in the next state budget, including the end of a health coverage program launched by former Gov. M. Jodi Rell to help the uninsured. One thing it doesn't change: Medicaid eligibility for low-income parents. Gov. Dannel P. Malloy had proposed restricting eligibility for the program, a move that would have caused an estimated 37,500 parents to lose Medicaid coverage (Phaneuf and Becker, 6/4).

6 Jun 2013

Sebelius defends phone calls to urge outreach support

At a House hearing Tuesday, Health and Human Services Secretary Kathleen Sebelius said she did not seek funds from companies, but did ask them to support the outreach efforts of Enroll America, a nonprofit group. She told panel members she made five calls on behalf of the organization.

6 Jun 2013

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Days after two landmark resolutions were adopted at the World Health Assembly - on neglected tropical diseases and on research and development, financing and coordination for the health needs of developing countries - over 400 scientists, representatives and ministers of health, ambassadors, national control programme representatives, African regulators, health workers, public health experts, and activists from 21 African countries and 10 others from around the world gather in Nairobi to take stock of health innovation for neglected diseases in Africa over the past decade.

6 Jun 2013

EMRs emerge as valuable resource for detecting bad drug reactions

NJIT Assistant Professor Mei Liu, PhD, a computer scientist, has recently shown in a new study that electronic medical records can validate previously reported adverse drug reactions and report new ones.

6 Jun 2013

Health care issues take Capitol Hill stage

Representatives from both sides of the aisle focused on various issues including "dual eligibles," veterans' health care, drug-tracking laws and the U.S. Preventive Services Task Force.

6 Jun 2013

BUSM researchers uncover important clues that may expand treatment options for schizophrenia

Researchers at Boston University School of Medicine have uncovered important clues about a biochemical pathway in the brain that may one day expand treatment options for schizophrenia.

6 Jun 2013

First Edition: June 5, 2013

Today's headlines include reports about the questions about fundraising phone calls faced by HHS Secretary Kathleen Sebelius during a Capitol Hill hearing.

5 Jun 2013

Study: New genetic marker predicts warfarin dose in African-Americans

A newfound genetic marker promises to better predict warfarin dose in African-Americans, according to a study published online today in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patient's starting dose misses the drug's narrow safety window.

5 Jun 2013

Viewpoints: Calif., Oregon exchanges curb premiums with limited networks; Why the U.S. pays so much for health care

A closer examination of these health plans (to be offered on the California and Oregon exchanges) reveals a less rosy picture. Although the premiums are lower than some anticipated, this has been achieved by designing the plans around much more limited provider networks and including greater cost-sharing than the typical commercial health-insurance plan. The premiums for the policies that will be offered on the states' exchanges are much higher than analogous plans being sold today (Daniel P. Kessler, 6/3).

5 Jun 2013

Healthcare market in Turkey to reach $29.62 billion in 2015, new analysis finds

Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases will enable Turkey to remain one of the sought-after countries for healthcare investment. Turkey offers immense potential for companies across the healthcare spectrum, from healthcare technology device suppliers to pharmaceutical and clinical diagnostic firms.

5 Jun 2013

Rubio proposes constitutional amendment to invalidate the health law's individual mandate

In other Capitol Hill action, the House approved a measure on Monday to set out how the government should track prescription drugs through the distribution chain.

5 Jun 2013

Young adults reduce drug misuse if they are part of community-based prevention effort

Prevention is often the best medicine, not only for physical health, but also public health, according to researchers at Penn State and Iowa State University.

5 Jun 2013

New plug-in optical sensor can help diagnose Kaposi's sarcoma

As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States.

5 Jun 2013

Study to help scientists better understand brain behavior, treat brain disease

A cross-disciplinary collaboration of researchers in the School of Science at Indiana University-Purdue University Indianapolis explores the neural synchrony between circuits in the brain and their behavior under simulated drug addiction.

5 Jun 2013

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

The last few years have seen the emergence of a new drug problem in so-called "bath salts"-actually "designer stimulants," packaged and sold in ways that skirt drug laws. A review and update on these designer drugs is presented in the June Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Jun 2013

UCLA researchers identify abnormal brain networks in Fragile X syndrome

The genetic malady known as Fragile X syndrome is the most common cause of inherited autism and intellectual disability. Brain scientists know the gene defect that causes the syndrome and understand the damage it does in misshaping the brain's synapses - the connections between neurons. But how this abnormal shaping of synapses translates into abnormal behavior is unclear.

5 Jun 2013

MJFF commits up to $10 million to find cure for Parkinson's disease

The Michael J. Fox Foundation for Parkinson's Research has committed up to $10 million to its next funding round for the Edmond J. Safra Core Programs for PD Research to prioritize research toward transformative treatments and a cure for Parkinson's disease.

5 Jun 2013

CSIRO scientists develop test to identify unsafe iPS cells

CSIRO scientists have developed a test to identify unsafe stem cells. It is the first safety test specifically for human induced pluripotent stem cells - as published today in the international journal Stem Cells.

5 Jun 2013

Revised CPG on treatment of osteoarthritis of the knee addresses two key changes

The American Academy of Orthopaedic Surgeons recently released its revised clinical practice guideline on the treatment of osteoarthritis of the knee, addressing two key changes.

5 Jun 2013

Drugs News and Research

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

State highlights: Conn. bill would maintain coverage for low-income parents; Wis. may pay hospitals for uninsured care; Is hospital data sale a risk to patient privacy?

Sebelius defends phone calls to urge outreach support

Sustained engagement, partnership needed to implement new treatments for neglected diseases

EMRs emerge as valuable resource for detecting bad drug reactions

Health care issues take Capitol Hill stage

BUSM researchers uncover important clues that may expand treatment options for schizophrenia

First Edition: June 5, 2013

Study: New genetic marker predicts warfarin dose in African-Americans

Viewpoints: Calif., Oregon exchanges curb premiums with limited networks; Why the U.S. pays so much for health care

Healthcare market in Turkey to reach $29.62 billion in 2015, new analysis finds

Rubio proposes constitutional amendment to invalidate the health law's individual mandate

Young adults reduce drug misuse if they are part of community-based prevention effort

New plug-in optical sensor can help diagnose Kaposi's sarcoma

Study to help scientists better understand brain behavior, treat brain disease

Review on new, hazardous drugs of abuse presented in Journal of Addiction Medicine

UCLA researchers identify abnormal brain networks in Fragile X syndrome

MJFF commits up to $10 million to find cure for Parkinson's disease

CSIRO scientists develop test to identify unsafe iPS cells

Revised CPG on treatment of osteoarthritis of the knee addresses two key changes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News